{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:07:18Z","timestamp":1794928038622,"version":"4.9.1"},"reference-count":117,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA210170"],"award-info":[{"award-number":["CA210170"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2019,9,28]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>The International Cancer of the Pancreas Screening Consortium met in 2018 to update its consensus recommendations for the management of individuals with increased risk of pancreatic cancer based on family history or germline mutation status (high-risk individuals).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A modified Delphi approach was employed to reach consensus among a multidisciplinary group of experts who voted on consensus statements. Consensus was considered reached if \u226575% agreed or disagreed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Consensus was reached on 55 statements. The main goals of surveillance (to identify high-grade dysplastic precursor lesions and T1N0M0 pancreatic cancer) remained unchanged. Experts agreed that for those with familial risk, surveillance should start no earlier than age 50 or 10 years earlier than the youngest relative with pancreatic cancer, but were split on whether to start at age 50 or 55. Germline\n                      <jats:italic>ATM<\/jats:italic>\n                      mutation carriers with one affected first-degree relative are now considered eligible for surveillance. Experts agreed that preferred surveillance tests are endoscopic ultrasound and MRI\/magnetic retrograde cholangiopancreatography, but no consensus was reached on how to alternate these modalities. Annual surveillance is recommended in the absence of concerning lesions. Main areas of disagreement included if and how surveillance should be performed for hereditary pancreatitis, and the management of indeterminate lesions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pancreatic surveillance is recommended for selected high-risk individuals to detect early pancreatic cancer and its high-grade precursors, but should be performed in a research setting by multidisciplinary teams in centres with appropriate expertise. Until more evidence supporting these recommendations is available, the benefits, risks and costs of surveillance of pancreatic surveillance need additional evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2019-319352","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T17:41:24Z","timestamp":1572543684000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":618,"title":["Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium"],"prefix":"10.1136","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-2296","authenticated-orcid":false,"given":"Michael","family":"Goggins","sequence":"first","affiliation":[{"name":"Pathology, Medicine Oncology, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-9963","authenticated-orcid":false,"given":"Kasper Alexander","family":"Overbeek","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Brand","sequence":"additional","affiliation":[{"name":"Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Syngal","sequence":"additional","affiliation":[{"name":"GI Cancer Genetics and Prevention Program, Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Del Chiaro","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef K","family":"Bartsch","sequence":"additional","affiliation":[{"name":"Division of Visceral, Thoracic and Vascular Surgery, University of Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bassi","sequence":"additional","affiliation":[{"name":"Department of Surgey, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Carrato","sequence":"additional","affiliation":[{"name":"Medical Oncology, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Farrell","sequence":"additional","affiliation":[{"name":"Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot K","family":"Fishman","sequence":"additional","affiliation":[{"name":"The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fockens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology & Metabolism, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-5461","authenticated-orcid":false,"given":"Thomas M","family":"Gress","sequence":"additional","affiliation":[{"name":"Gastroenterology, Endocrinology, Metabolism and Infectiology, University of Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanin E","family":"van Hooft","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Hruban","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay","family":"Kastrinos","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases, Columbia University Medical Center, New York City, New York, USA"},{"name":"Division of Digestive and Liver Diseases, Columbia University, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Klein","sequence":"additional","affiliation":[{"name":"Oncology, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Lennon","sequence":"additional","affiliation":[{"name":"Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Lucas","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-4188","authenticated-orcid":false,"given":"Walter","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases, Columbia University Medical Center, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Rustgi","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases, Columbia University, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Simeone","sequence":"additional","affiliation":[{"name":"New York University Medical Center, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Stoffel","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans F A","family":"Vasen","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuna L","family":"Cahen","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia Irene","family":"Canto","sequence":"additional","affiliation":[{"name":"Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bruno","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2025120521423896000_69.1.7.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.01.005"},{"key":"2025120521423896000_69.1.7.2","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-011-1781-6"},{"key":"2025120521423896000_69.1.7.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.02.005"},{"key":"2025120521423896000_69.1.7.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.171611"},{"key":"2025120521423896000_69.1.7.5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.65"},{"key":"2025120521423896000_69.1.7.6","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.276"},{"key":"2025120521423896000_69.1.7.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0730"},{"key":"2025120521423896000_69.1.7.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00244-7"},{"key":"2025120521423896000_69.1.7.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-010-9414-x"},{"key":"2025120521423896000_69.1.7.10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"2025120521423896000_69.1.7.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.11.048"},{"key":"2025120521423896000_69.1.7.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-3209"},{"key":"2025120521423896000_69.1.7.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS One"},{"key":"2025120521423896000_69.1.7.14","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ"},{"key":"2025120521423896000_69.1.7.15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3823"},{"key":"2025120521423896000_69.1.7.16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25148"},{"key":"2025120521423896000_69.1.7.17","doi-asserted-by":"crossref","unstructured":"Mukewar SS , Sharma A , Phillip N , et al . Risk of pancreatic cancer in patients with pancreatic cysts and family history of pancreatic cancer. Clin Gastroenterol Hepatol 2018.","DOI":"10.1016\/j.cgh.2018.01.049"},{"key":"2025120521423896000_69.1.7.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2012.04.004"},{"key":"2025120521423896000_69.1.7.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316027"},{"key":"2025120521423896000_69.1.7.20","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"2025120521423896000_69.1.7.21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"2025120521423896000_69.1.7.22","first-page":"5360","article-title":"Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas","volume":"56","author":"Goggins","year":"1996","journal-title":"Cancer Res"},{"key":"2025120521423896000_69.1.7.23","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0194"},{"key":"2025120521423896000_69.1.7.24","doi-asserted-by":"crossref","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"2025120521423896000_69.1.7.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1529"},{"key":"2025120521423896000_69.1.7.26","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0402"},{"key":"2025120521423896000_69.1.7.27","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.44"},{"key":"2025120521423896000_69.1.7.28","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2730"},{"key":"2025120521423896000_69.1.7.29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.6.442"},{"key":"2025120521423896000_69.1.7.30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.069"},{"key":"2025120521423896000_69.1.7.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720588115"},{"key":"2025120521423896000_69.1.7.32","doi-asserted-by":"crossref","unstructured":"Chaffee KG , Oberg AL , McWilliams RR , et al . Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med 2018;20.doi:10.1038\/gim.2017.85","DOI":"10.1038\/gim.2017.85"},{"key":"2025120521423896000_69.1.7.33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.11.042"},{"key":"2025120521423896000_69.1.7.34","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025120521423896000_69.1.7.35","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"2025120521423896000_69.1.7.36","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy024"},{"key":"2025120521423896000_69.1.7.37","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/j.gastro.2018.12.039","article-title":"Genetics of familial and sporadic pancreatic cancer","volume":"156","author":"Wood","year":"2019","journal-title":"Gastroenterology"},{"key":"2025120521423896000_69.1.7.38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","article-title":"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer","volume":"21","author":"Yurgelun","year":"2019","journal-title":"Genet Med"},{"key":"2025120521423896000_69.1.7.39","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-18-0014"},{"key":"2025120521423896000_69.1.7.40","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28662"},{"key":"2025120521423896000_69.1.7.41","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.18.01512","article-title":"Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance","volume":"37","author":"Abe","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025120521423896000_69.1.7.42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MPA.0000000000000725","article-title":"Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer","volume":"46","author":"Konings","year":"2017","journal-title":"Pancreas"},{"key":"2025120521423896000_69.1.7.43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.18.01489","article-title":"Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion","volume":"37","author":"Stoffel","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025120521423896000_69.1.7.44","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U"},{"key":"2025120521423896000_69.1.7.45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"2025120521423896000_69.1.7.46","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj465"},{"key":"2025120521423896000_69.1.7.47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jso.25376","article-title":"Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?","volume":"119","author":"Roch","year":"2019","journal-title":"J Surg Oncol"},{"key":"2025120521423896000_69.1.7.48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(19)31275-9","article-title":"Family health history: underused for actionable risk assessment","volume":"394","author":"Ginsburg","year":"2019","journal-title":"The Lancet"},{"key":"2025120521423896000_69.1.7.49","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp466"},{"key":"2025120521423896000_69.1.7.50","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1235-4","article-title":"Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case\u2013control study","volume":"8","author":"Potjer","year":"2015","journal-title":"BMC Res Notes"},{"key":"2025120521423896000_69.1.7.51","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cgh.2009.06.008","article-title":"Pancreatic cancer patients who smoke and drink are diagnosed at younger ages","volume":"7","author":"Brand","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025120521423896000_69.1.7.52","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.288"},{"key":"2025120521423896000_69.1.7.53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072311","article-title":"An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population","volume":"8","author":"Klein","year":"2013","journal-title":"PLoS One"},{"key":"2025120521423896000_69.1.7.54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2018.11.014","article-title":"Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals","volume":"19","author":"Zerboni","year":"2019","journal-title":"Pancreatology"},{"key":"2025120521423896000_69.1.7.55","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308008"},{"key":"2025120521423896000_69.1.7.56","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.gie.2019.01.030","article-title":"Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees","volume":"89","author":"Wani","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"2025120521423896000_69.1.7.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.08.030"},{"key":"2025120521423896000_69.1.7.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2006.09.018"},{"key":"2025120521423896000_69.1.7.59","first-page":"1067","article-title":"Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer","volume":"30","author":"Brune","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2025120521423896000_69.1.7.60","unstructured":"Thiruvengadam SS , Chuang J , Huang R , et al . Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Gastrointestinal endoscopy 2018."},{"key":"2025120521423896000_69.1.7.61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1148\/radiol.2015150217","article-title":"Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas: comparison between multidetector CT and MR imaging with MR cholangiopancreatography","volume":"279","author":"Kang","year":"2016","journal-title":"Radiology"},{"key":"2025120521423896000_69.1.7.62","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2019.01.039","article-title":"Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma","volume":"156","author":"Sah","year":"2019","journal-title":"Gastroenterology"},{"key":"2025120521423896000_69.1.7.63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"2025120521423896000_69.1.7.64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacr.2017.08.007","article-title":"Deep learning in radiology: now the real work begins","volume":"15","author":"Lugo-Fagundo","year":"2018","journal-title":"J Am Coll Radiol"},{"key":"2025120521423896000_69.1.7.65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2214\/AJR.18.20901","article-title":"Utility of CT Radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue","volume":"213","author":"Chu","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"2025120521423896000_69.1.7.66","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311098"},{"key":"2025120521423896000_69.1.7.67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00330-016-4377-4","article-title":"Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol","volume":"27","author":"Pozzi-Mucelli","year":"2017","journal-title":"Eur Radiol"},{"key":"2025120521423896000_69.1.7.68","doi-asserted-by":"crossref","unstructured":"Ashida R , Tanaka S , Yamanaka H , et al . The role of transabdominal ultrasound in the diagnosis of early stage pancreatic cancer: review and single-center experience. Diagnostics 2018;9.doi:10.3390\/diagnostics9010002","DOI":"10.3390\/diagnostics9010002"},{"key":"2025120521423896000_69.1.7.69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0365"},{"key":"2025120521423896000_69.1.7.70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0879"},{"key":"2025120521423896000_69.1.7.71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094928","article-title":"Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study","volume":"9","author":"Nolen","year":"2014","journal-title":"PLoS One"},{"key":"2025120521423896000_69.1.7.72","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2345"},{"key":"2025120521423896000_69.1.7.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.007"},{"key":"2025120521423896000_69.1.7.74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.10.040"},{"key":"2025120521423896000_69.1.7.75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jnci\/djy090","article-title":"Pancreatic cancer following incident diabetes in African Americans and Latinos: the multiethnic cohort","volume":"111","author":"Setiawan","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2025120521423896000_69.1.7.76","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"2025120521423896000_69.1.7.77","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.11.046","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes","volume":"152","author":"Boursi","year":"2017","journal-title":"Gastroenterology"},{"key":"2025120521423896000_69.1.7.78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704961114"},{"key":"2025120521423896000_69.1.7.79","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247"},{"key":"2025120521423896000_69.1.7.80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"2025120521423896000_69.1.7.81","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0197"},{"key":"2025120521423896000_69.1.7.82","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1200\/JCO.2017.77.6658","article-title":"Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer","volume":"36","author":"Mellby","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025120521423896000_69.1.7.83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5583","article-title":"Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers","volume":"9","author":"Kim","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025120521423896000_69.1.7.84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3226","article-title":"Multiparametric plasma eV profiling facilitates diagnosis of pancreatic malignancy","volume":"9","author":"Yang","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025120521423896000_69.1.7.85","doi-asserted-by":"crossref","unstructured":"Pea A , Yu J , Marchionni L , et al . Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases. Ann Surg 2018:1.doi:10.1097\/SLA.0000000000003022","DOI":"10.1097\/SLA.0000000000003022"},{"key":"2025120521423896000_69.1.7.86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.surg.2019.04.003","article-title":"Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life","volume":"166","author":"Partelli","year":"2019","journal-title":"Surgery"},{"key":"2025120521423896000_69.1.7.87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hpb.2017.08.034","article-title":"Prognosis of sporadic resected small (\u22642 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study","volume":"20","author":"Sallinen","year":"2018","journal-title":"HPB"},{"key":"2025120521423896000_69.1.7.88","doi-asserted-by":"publisher","DOI":"10.1159\/000443171"},{"key":"2025120521423896000_69.1.7.89","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308653"},{"key":"2025120521423896000_69.1.7.90","doi-asserted-by":"crossref","DOI":"10.1186\/s13053-018-0100-6","article-title":"German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program","volume":"16","author":"Franke","year":"2018","journal-title":"Hered Cancer Clin Pract"},{"key":"2025120521423896000_69.1.7.91","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pan.2015.05.478","article-title":"Quality assessment of the guidelines on cystic neoplasms of the pancreas","volume":"15","author":"Falconi","year":"2015","journal-title":"Pancreatology"},{"key":"2025120521423896000_69.1.7.92","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310162"},{"key":"2025120521423896000_69.1.7.93","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00268-016-3552-8","article-title":"A contemporary evaluation of the cause of death and long-term quality of life after total pancreatectomy","volume":"40","author":"Wu","year":"2016","journal-title":"World J Surg"},{"key":"2025120521423896000_69.1.7.94","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4240\/wjgs.v8.i9.634","article-title":"Total pancreatectomy: short- and long-term outcomes at a high-volume pancreas center","volume":"8","author":"Zakaria","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"2025120521423896000_69.1.7.95","unstructured":"Canto MI , Almario JA , Schulick RD , et al . Risk of neoplastic progression in high-risk individuals undergoing long-term surveillance for pancreatic cancer. Gastroenterology 2018."},{"key":"2025120521423896000_69.1.7.96","doi-asserted-by":"crossref","unstructured":"Canto MI , Kerdsirichairat T , Yeo CJ , et al . Surgical outcomes after pancreatic resection of screening-detected lesions in individuals at high risk for developing pancreatic cancer. J Gastrointest Surg. In Press 2019;29.doi:10.1007\/s11605-019-04230-z","DOI":"10.1007\/s11605-019-04230-z"},{"key":"2025120521423896000_69.1.7.97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/SLA.0b013e3182a690ff","article-title":"Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection","volume":"259","author":"Tamura","year":"2014","journal-title":"Ann Surg"},{"key":"2025120521423896000_69.1.7.98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/SLA.0000000000001817","article-title":"Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas","volume":"266","author":"Pea","year":"2017","journal-title":"Ann Surg"},{"key":"2025120521423896000_69.1.7.99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-018-0481-8","article-title":"Precancerous neoplastic cells can move through the pancreatic ductal system","volume":"561","author":"Makohon-Moore","year":"2018","journal-title":"Nature"},{"key":"2025120521423896000_69.1.7.100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41379-018-0183-7","article-title":"Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary","volume":"32","author":"Luchini","year":"2019","journal-title":"Mod Pathol"},{"key":"2025120521423896000_69.1.7.101","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41431-018-0170-y","article-title":"Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers","volume":"26","author":"Ibrahim","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"2025120521423896000_69.1.7.102","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000533"},{"key":"2025120521423896000_69.1.7.103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0004"},{"key":"2025120521423896000_69.1.7.104","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311166"},{"key":"2025120521423896000_69.1.7.105","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315062"},{"key":"2025120521423896000_69.1.7.106","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2463"},{"key":"2025120521423896000_69.1.7.107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.5260","article-title":"Why is pancreatic cancer so deadly? the pathologist's view","volume":"248","author":"Hruban","year":"2019","journal-title":"J Pathol"},{"key":"2025120521423896000_69.1.7.108","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02942-5","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer","volume":"9","author":"Klein","year":"2018","journal-title":"Nat Commun"},{"key":"2025120521423896000_69.1.7.109","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3686"},{"key":"2025120521423896000_69.1.7.110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MPA.0000000000001268","article-title":"Cost-effectiveness of pancreatic cancer surveillance in high-risk individuals","volume":"48","author":"Corral","year":"2019","journal-title":"Pancreas"},{"key":"2025120521423896000_69.1.7.111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MPA.0000000000001299","article-title":"Is the early detection of pancreatic cancer possible? it is good news, bad news","volume":"48","author":"Hruban","year":"2019","journal-title":"Pancreas"},{"key":"2025120521423896000_69.1.7.112","first-page":"438","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement methods and rationale for the early detection of pancreatic cancer. Highlights from the \"2010 ASCO Gastrointestinal Cancers Symposium\". Orlando, FL, USA. January 22-24, 2010","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"2025120521423896000_69.1.7.113","unstructured":"USPSTF . Pancreatic cancer: screening, 2019. Available: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/pancreatic-cancer-screening [Accessed 13 Apr 19]."},{"key":"2025120521423896000_69.1.7.114","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39470.643218.94"},{"key":"2025120521423896000_69.1.7.115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1008369"},{"key":"2025120521423896000_69.1.7.116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1510443"},{"key":"2025120521423896000_69.1.7.117","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/bjs5.50180","article-title":"Detection and outcome of pancreatic cancer surveillance in high-risk individuals: results from the caps Consortium","volume":"3","author":"Konings","year":"2019","journal-title":"BJS open"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-319352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:42:57Z","timestamp":1764999777000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-319352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,6]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/gutjnl-2019-319352"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-319352","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}